INTRODUCTION
It is a great honor for me to have been chosen as the recipient of the Hoechst-Roussel Award. I fully realize that this award was presented to me on behalf of the antibiotic research group at the Kitasato Institute and of outside researchers who have worked so diligently with me in the discovery of new antibiotics and their practical applications. It gives me great pleasure to have this opportunity to publish my point of view about our research work and the discovery of new antibiotics and bioactive compounds.
I have been working diligently on finding new antibiotics and on chemical and biological studies of these new compounds. Table 1 shows the antibiotics and other biologically active substances which we have discovered by various screening systems. Referring to some of these compounds, I would like to present my viewpoint and ideas on research work. These achievements have been produced by (i) believing in the great capabilities of microorganisms, (ii) establishing a welldesigned screening system for desired substances, (iii) recognizing that screening is not just routine work, (iv) emphasizing basic studies, and (v) treasuring good human relationships.
CAPABILITIES OF MICROORGANISMS
Besides antibiotics, microorganisms produce a number of biologically active substances such as plant growth factors, vitamins, alkaloids, enzymes, and enzyme inhibitors. One of the keys to the discovery of new drugs from microorganisms is to have a belief that the microorganisms can produce any desired substance. I have reached this belief based on my experiences.
Organic chemists clarify the structures of substances produced by living things. They also conduct chemical synthesis of natural products. rhey often say that they have synthesized non-natural compounds. However, during the course of screening for bioactive compounds, we have often experienced that the synthetic substances are found in the culture broths of microorganisms. These include 2'-amino-2'-deoxyribofuranosyladenine (antiviral and antimycoplasmal) (26, 123) , L-1H-1,2,4-triazole-3-alanine (histidine antagonistic) (20, 27) , quinoline-2-methanol (hypoglycemic) (63, 118) , pyrrole-2-carboxylic acid (antiviral) (42, 109) , and ,B-carboline carboxylic acid ethyl ester (benzodiazepine receptor binding activity) (4) . Long before these compounds were synthesized chemically, they must have been produced by microorganisms.
While we were studying the biosynthesis of macrolide antibiotics, we learned that microorganisms can perform simple but very interesting reactions. One example is the isomerization of isobutyrate to n-butyrate (Fig. 1 ). This explains clearly the mechanism by which valine is incorporated into the 16-membered lactone ring of leucomycin and tylosin (96) . We had never known previously such an interesting isomerization reaction in organic chemnistry. On the metabolic map, we can see many other reactions which are difficult to perform chemically.
These examples indicate that the microorganism is far more capable than we think of producing organic compounds with all possible structures. It is very likely that only those substances with a particular biological activity can be discovered by screening procedures.
It is also known that a natural compound can show various types of biological activity. I herewith provide some examples. The antimicrobial activity of erythromycin is well known. Besides this activity, erythromycin shows strong gastrointestinal motor stimulating activity, which is known to be the major side effect of the antibiotic (21) . This (44) , factumycin (14) , kinamycins (12) , , LA-1 (55), leucomycins (94) Japan, who is now working with us on the structure-side effect correlation (95) . The movement of the gastrointestine was recorded by setting transducers into a dog. Figure 2 shows a typical contractile wave on a polygraph when 0. (Fig. 5 ) (67), the toxic substance teleocidin (Fig.  6 ) (114), and LA-1 ( Fig. 7) with antibacterial activity (55), were isolated from Streptoverticillium sp. KA-6 (Fig. 8) .
In 1972, we reported for the first time a screening method for 3-lactamase inhibitors of microbial origin. It was to cope with the appearance of bacterial resistance to penicillins and cephalosporins (16) . Although the compounds we obtained at that time from four strains of Streptomyces spp. were macromolecular ones, efforts in this work led to the later discovery by other research groups of a number of 3-lactamase inhibitors of low molecular weight such as thienamycin (111), olivanic acid (6), and clavulanic acid (5) . (58) .
Another three new antibiotics were obtained as by-products of this screening process: asukamycin (28, 68) , setomimycin (29, 84) , and vineomycin (19, 85) . structure. This antibiotic was isolated from a culture broth of a new actinomycete, Pseudonocardia azii-rea (87, 110) . It induces lysis of growing B. (erelis at a concentration of 10 pLg/ml but does not affect resting cells. A study on the mode of action showed that the primary target of the antibiotic action is the transfer of the disaccharide peptide unit, GIcNAc-MurNac-pentapeptide, from lipid-bound precursor to the acceptor, nascent peptidoglycan, as shown in Fig. 10 . Nanaomycin ( Fig. 11 ) produced from S. rosa subsp. iotoetnsis ( Fig. 12 ) was named after the place where the soil sample was collected (30, 115) . Nanaomycin shows moderate antibacterial activity and strong activity against mycoplasma, as well as activity against Trichophyton spp. in vitro ( Table 2 ). Though we were unsuccessful in developing nanaomycin as an antimycoplasmal agent, Hamana and his co-workers (15) found that the complex has a remarkable in vivo effect against dermatomycosis of cattle. With a single application of 100 ppm of nanaomycin A, the dermatomycosis caused by Trichlophyton verrucosuin was healed in 1 month. After safety tests were conducted at Kyowa Hakko Kogyo Co. Ltd., nanaomycin A was approved as an antifungal antibiotic for veterinary use.
Biosynthesis of each component of the nanaomycin complex was studied by use of a cell-free system from S. rosa subsp. notoensis (116) . Three kinds of enzymes involved in nanaomycin biosynthesis were characterized (Fig. 13 ). Among them, nanaomycin D reductase, a flavoenzyme, was purified to homogeneity. Nanaomycin B synthase is the first enzyme known to convert an epoxide group to a monohydroxyl.
We proposed the mechanism of action of this antibiotic in a marine bacterium, Vibr-io alginolyticus (Fig. 14) . 16), is an antimycoplasmal substance with a unique structure. It is barely soluble in most solvents. Its structure was determined mainly by nuclear magnetic resonance spectroscopy of its methyl and triacetyl derivatives. The triacetate is highly soluble and as effective as clindamycin against various anaerobic and gram-positive bacteria (Table 3) .
Screening of Inhibitors of Folate-Related Metabolism
The next screening system is that used for antibiotics affecting folate-related metabolism. A microorganism used conventionally for folate bioassay was applied as the test organism (Fig. 17) .
Most microorganisms stop growing when folate biosynthesis is inhibited by sulfonamides, because they cannot take up folate from the outside. Enterococcus fJaecium, a strain which is used for folate bioassay, lacks a part of the enzyme assembly for folate biosynthesis, but it can take up folates to use for the biosynthesis of primary metabolites such as thymine and serine. Therefore, it is possible to examine whether a substance is an inhibitor of folate metabolism or not by observing the difference in antibacterial activities in the presence and absence of a folate-related substance added to a vitamin assay medium (Table 4) . For example, in the case of the inhibitor of thymidylate synthase, the inhibition would be reversed by thymidine, but not by pteroic or folic acid. A cultured broth of Streptomyces sp. strain OM-704 (Fig. 18 ) was found to show such an inhibitory pattern (59) . The inhibitor was named diazaquinomycin (Fig. 19 ) after its structure determination (74) . It is barely soluble in water, and the synthesis of its soluble derivative is being attempted in our laboratory. The antibiotic inhibits thymidylate synthase from E. faecium and from animal cells acting competitively with the normal substrate 5,10-methylenetetrahydrofolate ( 
Screening of Herbicidal Compounds by Using a Bacterium
This screening system shows how we obtained a herbicidal substance by using B. subtilis as a tool to detect biological activity.
Some synthetic herbicides inhibit glutamine biosynthesis in plant tissue, accumulating NH4' which kills the plant.
Based on this information, a screening system was designed to find a substance which inhibits growth of B. subtilis in minimal medium but not in the presence of glutamine. A very interesting substance, phosalacine, was discovered from a new organism, Kitasatosporia phosalacinea ( Fig. 21 ) (112) . Phosalacine was determined to be L-phosphinothricyl-L-alanyl-L-leucine ( Fig. 22 ) (71) . It has a broad herbicidal activity against mono-and dicotyledons. (Fig. 26) (78) . It is of particular interest that the phenyl group with three carbon units, the starter unit of the polyketide formation, originates from phenylalanine and the nitrogen of the lactam moiety originates from the (x-amino group of phenylalanine after migration to the ,B-position.
Irumamycin (Fig. 27) was isolated from S. siib fla'ius subsp. iruimaensis (Fig. 28) as an antifungal antibiotic (77, 91 (Fig. 29) , which was produced by Streptomnyces sp. strain AM-2604 (Fig. 30) , was found by screening for antiviral compounds (56, 82) . Besides its antiviral activity, this 18-membered macrolide antibiotic showed antitrichomonal activity.
Prumycin (Fig. 31) , which is produced by S. kagawaensis (Fig. 32) many possibilities of producing undiscovered bioactive substances.
Taxonomic Studies in the Screening of New Compounds
We make it a rule to conduct taxonomic studies on the producing strains when we find new substances, because we can apply the results of basic research, including cultivation and fermentation physiology, in our screening. One of the taxonomic studies led us to the discovery of a new genus of the family Actinomycetales, which we named KitasatoSpor-ia.
In the classification of actinomycetes, the type of cell wall constituent, together with morphological and physiological properties, are key characteristics (37) . It is very important whether Dpm contained in the cell wall is of the meso or LL type. Normally, one of the two types is contained in the cell wall of an actinomycete (Table 5 ). An interesting finding was that Kitasatosporia contains both types of Dpm. We have isolated three species of this genus, K. setae, K. griseola, and K. phosalacinea, which are producers of setamycin and phosalacine (83, 112) . Figure 33 shows various growth levels of K. setae in a submerged culture and the change of the mycelium into submerged spores. It contain LL-Dpm and the mycelia contain ineso-Dpm. This is a key characteristic of the genus Kitasatosporia (113).
Fermentation Conditions
During the course of our studies on macrolide biosynthesis, it was found that ammonium ion produced by the metabolism of nitrogen-containing compounds in the medium inhibits antibiotic production (89). We found a method to produce a large quantity of antibiotics by trapping NH4 with magnesium phosphate or zeolite to release the inhibition (Table 6 ). We just routine work. Thus each one of our group has a basic research assignment such as taxonomy, structure determination, mode of action, biosynthesis, or chemical synthesis, as well as participation in screening work. It is important for each researcher to enjoy being a pioneer in an undeveloped field, through the study of one's own new antibiotics, and at the same time to keep a challenging spirit to improve one's research capabilities. Although these may be merits in a computerized screening system, I am rather prudent about introducing a computer only for convenience, because it would make screening routine work.
Mode of Action of Cerulenin Referring to basic and applied studies of cerulenin, I would like to describe how one substance expanded the scope of research and led us to the discovery of new substances. After cerulenin was isolated from the culture broth of Cephalosporium caerulens (Fig. 34) (1, 103) , some attempts were made to develop this antibiotic into a chemotherapeutic agent for dermatomycosis. Unfortunately, it was unsuccessful because of its inflammatory side effect on the skin. Later, recollecting that this antibiotic has very broad antibacterial and antifungal spectra, we studied its mode of action to clarify why the antibiotic shows such a broad antimicrobial 
activity (51) . Cerulenin was found to be the first specific inhibitor of fatty acid biosynthesis.
Since then, many researchers, including K. Bloch of Harvard University, have collaborated with me in showing that cerulenin inhibits the condensation of acyl-acyl carrier protein and malonyl-acyl carrier protein, an important stage in fatty acid biosynthesis (Fig. 35) . The alkylation of the condensing enzyme with cerulenin, accompanied by the SN2 type of epoxide opening reaction, results in the loss of enzyme activity (Fig. 36) (10, 122) . Recently, our studies on the self-resistance mechanism of the cerulenin producer C. caerulens revealed that one of the active sites, the cysteine H3 -XF . , : '~~~~~~~~~~~~~~~~~~i 'q u, i t X 0!1' . . : . jS ,.a residue of the fatty acid synthase from this fungus, contains more polar amino acids such as glutamine and serine than those from sensitive eucaryotes such as Saccharomyces cerevisiae (31 researchers and has contributed greatly to progress in the biochemical field.
Cerulenin as a Tool for New Hybrid Antibiotics Further studies on the mechanism of cerulenin action showed that it inhibited biosynthesis of polyketide compounds. We now know that cerulenin inhibits the biosynthesis of polyketide antibiotics such as tetracycline, macrolides, and isochromanequinone antibiotics. Figure 37 shows the biosynthesis of nanaomycin and the site of action of cerulenin. Taking advantage of this mechanism of action, we have obtained a number of hybrid antibiotics (80, 99, 100) .
We tried to replace the aglycone of spiramycin with that of tylosin by a hybrid biosynthesis technique (Fig. 38) selected so as to inhibit the biosynthesis of the aglycone moiety of spiramycin but not to inhibit the growth of the organism. Then protylonolide, the lactone part of tylosin (which was obtained from a mutant of the tylosin-producing strain S. iradiae) was added to yield a new hybrid antibiotic named chimeramycin. Here, we need two microorganisms, S. ambofaciens KA-448 and S. fradiae to obtain the new hybrid antibiotic (Fig. 39) .
Recently, we were approached by D. A. Hopwood of John Innes Institute and H. Floss of Ohio State University to conduct coresearch work. Our joint study resulted in another new hybrid antibiotic, mederrhodin A (Fig. 40) 
Discovery of Salvarsan and Avermectin
I would like to recall the great international cooperation in the finding of salvarsan, one of the earliest chemotherapeutics (8) . Salvarsan is known as a specific chemotherapeutic for syphilis. The discovery of salvarsan in 1909 at George Speyer House in Germany, the first institute for experimental chemotherapy, resulted from international cooperation 
Avermectins
The producing organism of avermectin, S. avermitilis (Fig.  41) , was isolated in our laboratory and its excellent activity was found at the Merck Sharp & Dohme laboratory in a screening program using mice infected with Nematospiroides dubius (3) . The place where we collected the soil sample containing the novel actinomycete strain was close to the Kawana Golf Club in Shizuoka Prefecture, Japan.
Among many active components (Fig. 42) , avermectins Bla and Bib showed the highest activity. They were chemically reduced to dihydro derivatives with low toxicity. A mixture of dihydro derivatives was named ivermectin and is now being applied as an anthelmintic and an anti-mite drug for livestock. Recent clinical evaluation of ivermectin has suggested a great efficacy in the control of onchocerciasis in humans (2, 13, 36) . Research of the Merck Veterinary Institute has shown efficacy of ivermectin against endo-and exoparasites in horses, cattle, swine, and sheep (7). Table 7 shows how small a quantity of this antibiotic is effective. At a concentration of 1/1,000 that of diethylcarbamide, avermectin has a lethal effect on Caenorhabditis elegans, a soil nematode, in vitro.
The mode of action of avermectin has been studied by many researchers (9) . Avermectin shows antiparasite activity against levamisole-resistant C. elegans. This indicates that avermectin is not a nicotinic agonist. The inhibitory action of avermectin on the neuron in Ascaris suum is reversed by picrotoxin, an antagonist of -y-aminobutyric acid. These experimental data suggest that avermectin stimulates chloride ion conductance to block neuromuscular transmission (117) . PERSPECTIVE Recently it has been said that discovery of new antibiotics is becoming more and more difficult. However, the number of newly discovered antibiotics is increasing year by year. I believe this tendency will continue. From our past experience, we can see that one-third of the soil isolates tested produce antimicrobial substances. This productivity of antibiotics was observed by using two to three culture media under conventional incubation conditions. I hope that our further studies on fermentation physiology will allow us to discover the conditions which allow nonproducing strains to become producing strains.
More than 6,000 antibiotics have been discovered so far. As I earlier explained the differing physiological activities of erythromycin, it should be very interesting to study activities other than antibacterial activities. It 
